Benralizumab Depletes IL‐5Rα‐Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by tissue eosinophilia and itch. We evaluated the effect of eosinophil depletion with benralizumab on markers of inflammation in the skin of patients with AD. Methods After a 4‐week washout from oral anti...
Saved in:
| Main Authors: | Christiane E. Whetstone, Ruth P. Cusack, Emma L. Price, Karen J. Howie, Caitlin Stevens, Dhuha Al‐Sajee, Suzanne Beaudin, Jennifer Wattie, Nadia Alsaji, Abbey Schlatman, Vanessa Luk, Paul M. O'Byrne, Mark D. Inman, Roma Sehmi, Hermenio Lima, Gail M. Gauvreau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical and Translational Allergy |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/clt2.70090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors influencing the real-world effectiveness of benralizumab in uncontrolled asthma
by: María Del Mar Sánchez Suárez, et al.
Published: (2025-07-01) -
Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma
by: Anchalee Senavonge, et al.
Published: (2025-08-01) -
The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study
by: Alida Benfante, et al.
Published: (2025-07-01) -
Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
by: González-Tuyub YH, et al.
Published: (2024-11-01) -
Out of Breath, out of Options: Benralizumab as a Last Hope in ICU‐Treated Near‐Fatal Eosinophilic Asthma: A Case Series
by: Lennart Conemans, et al.
Published: (2025-03-01)